SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-06-22 18:59
Tx date 2022-06-22
$BCC
Benz Capital Corp.
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$420.00
+7,000 vol
$0.06 each
1,237,000
Filed 2022-06-20 04:04
Tx date 2022-06-13
$BCC
Benz Capital Corp.
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,650
+30,000 vol
$0.055 each
1,230,000
Filed 2022-06-07 11:16
Tx date 2022-05-16
$BCC
Benz Capital Corp.
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$950.00
+10,000 vol
$0.095 each
1,200,000
Filed 2022-06-07 11:15
Tx date 2022-05-13
$BCC
Benz Capital Corp.
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,900
+20,000 vol
$0.095 each
1,190,000
Filed 2021-10-25 20:35
Tx date 2021-10-21
$BCC
Benz Capital Corp.
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+5,000 vol
1,170,000
Filed 2021-10-12 20:34
Tx date 2021-10-06
$BCC
Benz Capital Corp.
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$14,900
+149,000 vol
$0.10 each
149,000
Filed 2021-10-12 20:33
Tx date 2021-10-04
$BCC
Benz Capital Corp.
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-10-12 20:33
Tx date 2021-10-04
$BCC
Benz Capital Corp.
Vicentijevic, Miloje
4 - Director of Issuer
Holder: Gordana Vicentijevic (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
50,000
Filed 2021-10-12 20:32
Tx date 2021-10-04
$BCC
Benz Capital Corp.
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
1,165,000
Filed 2021-10-12 20:14
Tx date 2021-10-06
$BCC
Benz Capital Corp.
Bub, Gordon
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$5,000
+50,000 vol
$0.10 each
50,000
Filed 2021-10-12 14:59
Tx date 2021-10-06
$BCC
Benz Capital Corp.
TINTOR, NICHOLAS
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$10,000
+100,000 vol
$0.10 each
100,000
Filed 2021-10-12 14:57
Tx date 2021-07-05
$BCC
Benz Capital Corp.
TINTOR, NICHOLAS
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-10-08 20:02
Tx date 2021-10-06
$BCC
Benz Capital Corp.
Bub, Gordon
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$2,500
+25,000 vol
$0.10 each
Filed 2021-10-08 20:46
Tx date 2021-10-06
$BCC
Benz Capital Corp.
Pankiw, Christine
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$5,000
+50,000 vol
$0.10 each
50,000
Filed 2021-10-08 20:45
Tx date 2021-07-05
$BCC
Benz Capital Corp.
Pankiw, Christine
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-10-08 20:44
Tx date 2021-10-06
$BCC
Benz Capital Corp.
Birmingham, Jason
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$7,500
+75,000 vol
$0.10 each
75,000
Filed 2021-10-08 20:43
Tx date 2021-07-05
$BCC
Benz Capital Corp.
Birmingham, Jason
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-10-08 20:02
Tx date 2021-10-06
$BCC
Benz Capital Corp.
Bub, Gordon
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$2,500
+25,000 vol
$0.10 each
25,000
Filed 2021-10-08 20:00
Tx date 2021-07-05
$BCC
Benz Capital Corp.
Bub, Gordon
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-10-07 13:51
Tx date 2021-10-04
$BCC
Benz Capital Corp.
Escribano, Carlos
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
500,000
Filed 2017-10-30
Tx date 2017-08-24
$BCC
The Canadian Bioceutical Corporation
Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately

-20,343,750 vol
0
Filed 2017-10-30
Tx date 2017-01-19
$BCC
The Canadian Bioceutical Corporation
Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
20,343,750
Filed 2017-10-30
Tx date 2017-08-22
$BCC
The Canadian Bioceutical Corporation
Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Shamsa Alotaiba (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately

-14,437,500 vol
0
Filed 2017-10-30
Tx date 2017-01-19
$BCC
The Canadian Bioceutical Corporation
Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Shamsa Alotaiba (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
14,437,500
Filed 2017-10-30
Tx date 2017-08-25
$BCC
The Canadian Bioceutical Corporation
Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Samih Abdulrahman Basaddiq (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately

-17,718,750 vol
0
Filed 2017-10-30
Tx date 2017-01-19
$BCC
The Canadian Bioceutical Corporation
Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Samih Abdulrahman Basaddiq (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
17,718,750
Filed 2017-10-30
Tx date 2017-08-25
$BCC
The Canadian Bioceutical Corporation
Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately

+17,718,750 vol
52,500,000
Filed 2017-10-30
Tx date 2017-08-24
$BCC
The Canadian Bioceutical Corporation
Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately

+20,343,750 vol
34,781,250
Filed 2017-10-30
Tx date 2017-01-19
$BCC
The Canadian Bioceutical Corporation
Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
14,437,500
Filed 2017-10-18
Tx date 2017-10-17
$BCC
The Canadian Bioceutical Corporation
Stott, Donald
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$30,000
+150,000 vol
$0.20 each
400,000
Filed 2017-10-18
Tx date 2017-10-17
$BCC
The Canadian Bioceutical Corporation
Stott, Donald
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$5,000
+100,000 vol
$0.05 each
250,000
Filed 2017-10-18
Tx date 2017-10-17
$BCC
The Canadian Bioceutical Corporation
Stott, Donald
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-30,000
-150,000 vol
$0.20 each
0
Filed 2017-10-18
Tx date 2017-10-17
$BCC
The Canadian Bioceutical Corporation
Stott, Donald
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-5,000
-100,000 vol
$0.05 each
150,000
Filed 2017-10-17
Tx date 2017-10-17
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$12,500
+250,000 vol
$0.05 each
2,611,559
Filed 2017-10-17
Tx date 2017-10-17
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$30,000
+150,000 vol
$0.20 each
2,361,559
Filed 2017-10-17
Tx date 2017-10-17
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-250,000 vol
0
Filed 2017-10-17
Tx date 2017-10-17
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-150,000 vol
250,000
Filed 2017-10-17
Tx date 2017-10-17
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-150,000 vol
Filed 2017-10-17
Tx date 2017-10-17
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$50,000
+250,000 vol
$0.20 each
Filed 2017-10-14
Tx date 2017-10-12
$BCC
The Canadian Bioceutical Corporation
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
Common Shares
51 - Exercise of options
$30,000
+150,000 vol
$0.20 each
396,000
Filed 2017-10-13
Tx date 2017-10-10
$BCC
The Canadian Bioceutical Corporation
Layman, David J
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-30,000
-150,000 vol
$0.20 each
0
Filed 2017-07-04
Tx date 2017-06-29
$BCC
The Canadian Bioceutical Corporation
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
Common Shares
51 - Exercise of options
$5,250
+105,000 vol
$0.05 each
246,000
Filed 2017-05-06
Tx date 2017-05-05
$BCC
The Canadian Bioceutical Corporation
Layman, David J
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-5,250
-105,000 vol
$0.05 each
150,000
Filed 2017-04-21
Tx date 2017-01-25
$BCC
The Canadian Bioceutical Corporation
Chu, Jonathan
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$100,000
+500,000 vol
$0.20 each
500,000
Filed 2017-04-21
Tx date 2016-10-01
$BCC
The Canadian Bioceutical Corporation
Chu, Jonathan
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-03-29
Tx date 2017-03-28
$BCC
The Canadian Bioceutical Corporation
Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,600
+20,000 vol
$0.53 each
207,500
Filed 2017-03-20
Tx date 2017-03-17
$BCC
The Canadian Bioceutical Corporation
Stott, Donald
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$7,500
+150,000 vol
$0.05 each
150,000
Filed 2017-03-20
Tx date 2017-03-17
$BCC
The Canadian Bioceutical Corporation
Stott, Donald
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-7,500
-150,000 vol
$0.05 each
250,000
Filed 2017-02-24
Tx date 2017-01-25
$BCC
The Canadian Bioceutical Corporation
Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$700,000
+3,500,000 vol
$0.20 each
Filed 2017-02-24
Tx date 2017-01-25
$BCC
The Canadian Bioceutical Corporation
Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$700,000
+3,500,000 vol
$0.20 each
Filed 2017-02-24
Tx date 2017-01-23
$BCC
The Canadian Bioceutical Corporation
Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
Promissory Notes
00 - Opening Balance-Initial SEDI Report
Filed 2017-02-24
Tx date 2017-01-25
$BCC
The Canadian Bioceutical Corporation
Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$3,500,000
+3,500,000 vol
$1.00 each
10,500,000
Filed 2017-02-24
Tx date 2017-01-25
$BCC
The Canadian Bioceutical Corporation
Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$3,500,000
+3,500,000 vol
$1.00 each
Filed 2017-02-24
Tx date 2017-01-25
$BCC
The Canadian Bioceutical Corporation
Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$2,100,000
+3,500,000 vol
$0.60 each
7,000,000
Filed 2017-02-24
Tx date 2017-01-25
$BCC
The Canadian Bioceutical Corporation
Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$700,000
+3,500,000 vol
$0.20 each
3,500,000
Filed 2017-02-24
Tx date 2017-01-23
$BCC
The Canadian Bioceutical Corporation
Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-02-23
Tx date 2017-02-16
$BCC
The Canadian Bioceutical Corporation
Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership

-62,500 vol
187,500
Filed 2017-02-23
Tx date 2014-11-18
$BCC
The Canadian Bioceutical Corporation
Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Cindy Eikens-Stafford (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-02-23
Tx date 2017-02-16
$BCC
The Canadian Bioceutical Corporation
Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Cindy Eikens-Stafford (Control or Direction)
Common Shares
90 - Change in the nature of ownership

+62,500 vol
62,500
Filed 2017-02-23
Tx date 2017-02-16
$BCC
The Canadian Bioceutical Corporation
Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership

-62,500 vol
Filed 2017-02-01
Tx date 2017-01-25
$BCC
The Canadian Bioceutical Corporation
BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$700,000
+3,500,000 vol
$0.20 each
3,650,000
Filed 2017-01-31
Tx date 2017-01-25
$BCC
The Canadian Bioceutical Corporation
Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$30,000
+150,000 vol
$0.20 each
300,000
Filed 2017-01-31
Tx date 2017-01-25
$BCC
The Canadian Bioceutical Corporation
Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$30,000
+150,000 vol
$0.20 each
150,000
Filed 2017-01-31
Tx date 2017-01-25
$BCC
The Canadian Bioceutical Corporation
Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-8,500
-170,000 vol
$0.05 each
0
Filed 2017-01-31
Tx date 2017-01-25
$BCC
The Canadian Bioceutical Corporation
Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$8,500
+170,000 vol
$0.05 each
250,000
Filed 2017-01-27
Tx date 2017-01-26
$BCC
The Canadian Bioceutical Corporation
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
Common Shares
51 - Exercise of options
$1,500
+30,000 vol
$0.05 each
141,000
Filed 2017-01-26
Tx date 2017-01-25
$BCC
The Canadian Bioceutical Corporation
Stott, Donald
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$30,000
+150,000 vol
$0.20 each
400,000
Filed 2017-01-26
Tx date 2016-09-24
$BCC
The Canadian Bioceutical Corporation
Stott, Donald
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-386,265 vol
250,000
Filed 2017-01-25
Tx date 2017-01-25
$BCC
The Canadian Bioceutical Corporation
Layman, David J
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$30,000
+150,000 vol
$0.20 each
255,000
Filed 2017-01-25
Tx date 2017-01-25
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$30,000
+150,000 vol
$0.20 each
400,000
Filed 2017-01-06
Tx date 2017-01-03
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
97 - Other

-180,000 vol
2,031,559
Filed 2017-01-06
Tx date 2017-01-03
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
97 - Other

+180,000 vol
2,211,559
Filed 2017-01-02
Tx date 2016-12-29
$BCC
The Canadian Bioceutical Corporation
Layman, David J
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-1,500
-30,000 vol
$0.05 each
105,000
Filed 2016-10-25
Tx date 2016-10-21
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership

+2,211,559 vol
2,211,559
Filed 2016-10-25
Tx date 2016-10-21
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership

-2,211,559 vol
0
Filed 2016-10-24
Tx date 2016-09-24
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-49,800
-166,000 vol
$0.30 each
250,000
Filed 2016-10-24
Tx date 2016-10-21
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Palm American Investments Inc. (Control or Direction)
Common Shares
97 - Other

-196,771 vol
0
Filed 2016-09-29
Tx date 2016-09-22
$BCC
The Canadian Bioceutical Corporation
Layman, David J
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-1,750
-35,000 vol
$0.05 each
135,000
Filed 2016-09-29
Tx date 2016-09-22
$BCC
The Canadian Bioceutical Corporation
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Indirect Ownership)
Common Shares
51 - Exercise of options
$1,750
+35,000 vol
$0.05 each
111,000
Filed 2016-06-20
Tx date 2014-12-16
$BCC
The Canadian Bioceutical Corporation
Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$12,500
+250,000 vol
$0.05 each
Filed 2016-06-20
Tx date 2016-06-17
$BCC
The Canadian Bioceutical Corporation
Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-4,000
-80,000 vol
$0.05 each
170,000
Filed 2016-06-20
Tx date 2016-06-17
$BCC
The Canadian Bioceutical Corporation
Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-40,000
-80,000 vol
$0.50 each
Filed 2016-06-20
Tx date 2014-12-16
$BCC
The Canadian Bioceutical Corporation
Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$12,500
+250,000 vol
$0.05 each
250,000
Filed 2016-06-20
Tx date 2014-11-18
$BCC
The Canadian Bioceutical Corporation
Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-20
Tx date 2016-06-17
$BCC
The Canadian Bioceutical Corporation
Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$4,000
+80,000 vol
$0.05 each
80,000
Filed 2016-06-17
Tx date 2016-06-17
$BCC
The Canadian Bioceutical Corporation
Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-40,000
-80,000 vol
$0.50 each
170,000
Filed 2016-06-17
Tx date 2014-11-18
$BCC
The Canadian Bioceutical Corporation
Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-17
Tx date 2014-11-18
$BCC
The Canadian Bioceutical Corporation
Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-05-17
Tx date 2016-05-11
$BCC
The Canadian Bioceutical Corporation
Layman, David J
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-2,000
-40,000 vol
$0.05 each
170,000
Filed 2016-05-17
Tx date 2016-05-11
$BCC
The Canadian Bioceutical Corporation
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
Common Shares
51 - Exercise of options
$2,000
+40,000 vol
$0.05 each
76,000
Filed 2016-01-13
Tx date 2016-01-11
$BCC
The Canadian Bioceutical Corporation
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-800.00
-4,000 vol
$0.20 each
36,000
Filed 2015-12-24
Tx date 2015-12-23
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
97 - Other

+19,500 vol
2,211,559
Filed 2015-12-24
Tx date 2015-12-23
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
97 - Other

-19,500 vol
2,192,059
Filed 2015-12-01
Tx date 2015-11-27
$BCC
The Canadian Bioceutical Corporation
BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-22,500
-125,000 vol
$0.18 each
3,911,000
Filed 2015-11-07
Tx date 2015-11-03
$BCC
The Canadian Bioceutical Corporation
Layman, David J
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-1,250
-25,000 vol
$0.05 each
210,000
Filed 2015-11-07
Tx date 2015-11-03
$BCC
The Canadian Bioceutical Corporation
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
Common Shares
51 - Exercise of options
$1,250
+25,000 vol
$0.05 each
40,000
Filed 2015-09-17
Tx date 2015-09-16
$BCC
The Canadian Bioceutical Corporation
BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants CSW - 2014
54 - Exercise of warrants

-615,000 vol
50,000
Filed 2015-09-17
Tx date 2015-09-14
$BCC
The Canadian Bioceutical Corporation
Collagenna skin care products
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$30,750
+615,000 vol
$0.05 each
3,980,000
Filed 2015-09-17
Tx date 2015-03-20
$BCC
The Canadian Bioceutical Corporation
Collagenna skin care products
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$30,750
+615,000 vol
$0.05 each
3,365,000
Filed 2015-09-17
Tx date 2014-11-19
$BCC
The Canadian Bioceutical Corporation
Collagenna skin care products
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
2,750,000
Filed 2015-09-17
Tx date 2015-09-16
$BCC
The Canadian Bioceutical Corporation
BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$30,750
+615,000 vol
$0.05 each
4,036,000
Filed 2015-08-14
Tx date 2015-08-12
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-800.00
-2,000 vol
$0.40 each
2,214,559
Filed 2015-08-14
Tx date 2015-08-13
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,350
-3,000 vol
$0.45 each
2,211,559
Filed 2015-07-31
Tx date 2015-07-29
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,850
-5,000 vol
$0.37 each
2,216,559
Filed 2015-07-15
Tx date 2014-11-18
$BCC
The Canadian Bioceutical Corporation
BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-07-15
Tx date 2015-07-09
$BCC
The Canadian Bioceutical Corporation
BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$27,750
+150,000 vol
$0.185 each
150,000
Filed 2015-07-15
Tx date 2015-07-14
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,600
-5,000 vol
$0.32 each
2,221,559
Filed 2015-07-10
Tx date 2015-07-06
$BCC
The Canadian Bioceutical Corporation
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
Common Shares
51 - Exercise of options
$750.00
+15,000 vol
$0.05 each
15,000
Filed 2015-07-10
Tx date 2015-07-06
$BCC
The Canadian Bioceutical Corporation
Layman, David J
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-750.00
-15,000 vol
$0.05 each
235,000
Filed 2015-07-10
Tx date 2014-11-18
$BCC
The Canadian Bioceutical Corporation
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-05-22
Tx date 2015-05-21
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,400
-5,000 vol
$0.28 each
2,226,559
Filed 2015-05-13
Tx date 2015-05-13
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-675.00
-2,500 vol
$0.27 each
2,231,559
Filed 2015-05-11
Tx date 2015-05-08
$BCC
The Canadian Bioceutical Corporation
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-130.00
-500 vol
$0.26 each
2,234,059